Hyperliquid ETFs Outside the US: Europe, Canada and the Fee Gap

TL;DR. Europe got Hyperliquid exposure first. 21Shares listed a Swiss-domiciled staking ETP under the ticker HYPE on 28 August 2025, nine months before any US fund, and Bitwise Europe and VanEck followed on Deutsche Börse Xetra in April and May 2026. The catch is cost: the Swiss product carries a 2.50% total expense ratio against 0.29% to 0.34% in the US. Canada has no listed HYPE product, so Canadian investors reach the asset through US-listed funds at their broker. European retail investors generally can't do the same, because PRIIPs rules block US ETFs.

Europe was first, by nine months

The US spot funds get the coverage, but they weren't the first regulated HYPE wrappers anywhere. 21Shares listed its Hyperliquid Staking ETP on SIX Swiss Exchange on 28 August 2025 under the ticker HYPE, ISIN CH1471826029, at a time when no US issuer had even received a hearing.

That order of events is normal. Europe uses an exchange-traded note structure that doesn't require the fund-registration machinery a US ETF does, so European issuers routinely list niche crypto products years ahead of their American counterparts. The trade-off is that an ETN is a debt instrument backed by collateral rather than a trust holding the asset for you, and issuer risk is a real if usually small consideration.

What's actually listed in Europe

Product	Ticker / ISIN	Venue	Listed	Notes
21Shares Hyperliquid Staking ETP	HYPE / CH1471826029	SIX Swiss Exchange	28 Aug 2025	2.50% TER, Swiss-domiciled, ~€17m AUM
Bitwise Hyperliquid Staking ETP	BHYP	Deutsche Börse Xetra	9 Apr 2026	Tracks the Kaiko HYPE Reference Rate
VanEck Hyperliquid ETN	VHRL / DE000A4AT2X6	Xetra	28 May 2026	Collateral held at Bank Frick

Note the ticker collision: Bitwise uses BHYP for both its European ETP and its US ETF, and they are different instruments with different structures, domiciles and fee schedules. Check the exchange before you place an order.

The fee gap is the story

2.50% against 0.29% is not a rounding difference. On a €10,000 position held for three years, the Swiss ETP costs roughly €750 in fees where the cheapest US fund would cost about €87.

Three things explain the gap, and only one of them is a good reason:

• Scale. A product with €17m in assets cannot spread fixed costs the way a $141m fund can. This is legitimate.
• Competition. The US has three funds fighting for the same money and a public fee war. Europe's products list on different venues and compete less directly.
• Legacy pricing. European crypto ETPs launched at 2–2.5% when they were the only regulated route to the asset, and those levels have been slow to fall.

The same pattern showed up in Bitcoin: European ETPs charged 1–2% for years while US funds arrived in 2024 at 0.19–0.25% and dragged the whole market down. Expect pressure on European HYPE fees, but not quickly.

Why European investors can't just buy the US funds

The obvious workaround, buy HYPG at 0.29% through a European broker, is closed to most retail investors in the EU. The Packaged Retail and Insurance-based Investment Products regulation requires a Key Information Document in the local language, and US issuers don't produce them. Without a KID, a broker can't offer the fund to a retail client.

Two exceptions exist. Professional and elective-professional clients aren't covered by the retail restriction, and investors in Switzerland and the UK sit outside EU PRIIPs, though UK rules impose their own constraints. For most European retail buyers the practical choice is a local ETP at a higher fee, or holding the token directly.

Does the European product stake?

The 21Shares product is named a Staking ETP, and the name is accurate: it stakes HYPE and the rewards accrue to the note. Bitwise Europe's Xetra listing is likewise a staking ETP. That matters when comparing costs, because a 2.50% fee against a staking reward near 2.2% gross leaves the holder paying to hold, while a 0.29% US fund with the same reward has positive carry.

Run the arithmetic on a €10,000 position over a year, assuming a 2.2% gross reward and the sponsor keeping a quarter of it:

	Swiss ETP at 2.50%	US fund at 0.29%
Net staking contribution	~+€165	~+€158
Fee	−€250	−€29
Net carry before price	−€85	+€129

These are estimates from published terms rather than reported fund performance, and the staked proportion differs between products. But the direction is not in doubt: geography currently costs a European holder more than two percentage points a year on the same underlying token.

Canada: nothing listed

Canada was early to crypto ETFs, approving the world's first spot Bitcoin ETF in February 2021, more than two years before the US. On Hyperliquid, no Canadian issuer has listed a product as of August 2026.

That's less surprising than it sounds. Canadian crypto ETFs concentrate on the assets with institutional demand, chiefly Bitcoin, Ether and Solana, and the domestic market is small enough that a niche token with a couple of hundred million dollars of global fund assets doesn't clear the bar.

Canadian investors are also better placed than European ones. Canada has no PRIIPs equivalent, so US-listed ETFs are widely available through Canadian brokerages, and the US funds are the cheapest HYPE wrappers in existence. The considerations are currency exposure, the 15% US withholding on distributions in a taxable account, and the treaty exemption that generally applies inside an RRSP.

What the flow data can and can't see

One practical consequence of this geography worth knowing if you follow the numbers: published Hyperliquid ETF flow data covers the US funds. European ETP creations and redemptions are reported separately by each issuer, on different schedules and in different formats, and there's no consolidated tape for them.

So when a tracker says the Hyperliquid complex drew $287.8m through 20 August 2026, that's the three US funds. Add the European products and the true figure is higher, though not by much: the Swiss ETP held around €17m, and the Xetra listings are newer and smaller still. Call it a few percent of the total.

The gap matters more for interpretation than for size. European demand appeared nine months before American demand and stayed modest, which suggests the asset's institutional bid is genuinely US-centred rather than global. That's consistent with what the daily prints show on our flows page, where the pattern has been small, frequent US tickets rather than large scheduled allocations.

How to choose, by where you live

• United States: use the domestic funds. BHYP, THYP or HYPG at 0.29–0.34%, compared in BHYP vs THYP vs HYPG.
• Canada: US-listed funds through a Canadian broker. An RRSP generally avoids US withholding on distributions; a taxable account does not.
• EU: a local ETP at 2%+, or the token directly. Professional clients may be able to access US funds.
• Switzerland and the UK: the Swiss ETP is domestic; check whether your broker offers US listings, since rules differ from the EU.
• Elsewhere: depends entirely on the broker. Many international platforms offer US-listed ETFs without difficulty.

What would change this

Two developments would matter. A Canadian listing, most plausibly from an issuer that already runs Solana or XRP products, would give Canadians a domestic option in Canadian dollars. And fee compression in Europe, which competition eventually forces, would narrow a gap that currently makes geography the largest single determinant of what HYPE exposure costs.

Neither looks imminent. For now, the US funds are the cheapest wrappers available anywhere, and whether you can reach them depends on your passport more than your portfolio.

FAQ

Sources and further reading

• 21Shares, Hyperliquid Staking ETP (HYPE) product page and factsheet — 21shares.com.
• VanEck, Hyperliquid ETN (VHRL) product page — vaneck.com.
• Bitwise Europe, Hyperliquid Staking ETP listing on Xetra — bitwiseinvestments.com.
• Internal: how to buy a Hyperliquid ETF, daily US flows.